blog-featured-img

Covid-19 News & our involvement

dnature has been in the media recently – the attached links are to articles in the New Zealand media on how we were able to assist in getting New Zealand laboratories underway with Covid-19 testing.

blog-featured-img

PRESS RELEASE – dnature secures HRC funding for a 15 minute DNA diagnostic test for COVID-19

The Health Research Council, announced on Friday 17 April, that dnature diagnostics & research ltd were the recipients of funding for the purpose of developing a rapid.

blog-featured-img

RNZ interview with John Mackay on COVID-19 testing

On Monday, John was interviewed by Radio New Zealand on the testing in New Zealand for Covid-19 as well as the work that dnature is doing to support this.

blog-featured-img

Covid-19, the Mic & Myra in action

BioMolecular Systems, our Australian supplier of the Mic & Myra, are at the forefront of testing for Covid-19 in Australia.

blog-featured-img

Integra promotion

As many of you know, here in our lab at dnature, we absolutely love our Integra Viaflo Electronic Pipettes and we know that our customers do too. Some of the feedback that we’ve received includes:

blog-featured-img

The solution (of your primers)

As PCR primers become less expensive, is there less care being paid to them? Throw in a diluent,a quick vortex and dilute for PCR?

blog-featured-img

Launch of Milk & Dairy DNA testing

DNA testing allows fast, sensitive and specific detection of particular target organisms & biological products.

blog-featured-img

American Foulbrood testing

American Foulbrood is a notifiable, bacterial disease that, if found, is required to be reported to the AFB management agency as well as the hive being destroyed.

blog-featured-img

American Foulbrood testing

American Foulbrood is a notifiable, bacterial disease that, if found, is required to be reported to the AFB management agency Read More

blog-featured-img

World famous in Gisborne

Our local paper, every three months, features a Tairawhiti Gisborne business and this quarter it was our turn to showcase Read More